NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Main Sequence

Main Sequence

Sydney, New South Walesmainsequence.com

Overview

Main Sequence is an Australian deep tech investment fund founded by Australia's national science agency, CSIRO. It invests in spinouts, startups, and SMEs connected to Australia's publicly funded R&D sector, aiming to solve global challenges across health, food, space, transport, security, and decarbonisation. The firm invests from seed to Series B and employs a 'Venture Science' model, working closely with scientists and researchers to build companies from scratch.

Year Founded

2017

Portfolio Companies

26

Investments

Main Sequence investments
CompanyDateStageLead
Number 8 BioNov 2025Series ACo-investor
The EVERY CompanyNov 2025Series DCo-investor
UluuOct 2025Series ACo-investor
Morse MicroSep 2025Series CCo-investor
Andromeda RoboticsSep 2025Series ACo-investor

Key People

Phil Morle

Partner

Sector & Stage Mix

Industry, funding stage, and valuation band breakdowns.

Premium
SeedSeries ASeries BGrowth

Unlock portfolio analytics

Sign up to view full sector, stage, and valuation breakdowns for this investor.

Investment Activity

Yearly cadence, pace, and funding raised over time.

Premium
2021
2022
2023
2024
2025
2026

Unlock portfolio analytics

Sign up to explore yearly investment trends and funding raised over time.

FAQ

Firmographic Details

HeadquartersSydney, New South Wales
Year Founded2017

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.